Skip to main content
Clinical Trials/NCT03153891
NCT03153891CompletedNot Applicable

Virtual Nature: Benefits for Older Adults Who Experience Chronic Pain?

Cornell University2 sites in 1 country23 target enrollmentStarted: July 1, 2016Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
23
Locations
2
Primary Endpoint
Experience of chronic pain

Study Overview

Brief Summary

This randomized controlled trial examines the effect of nature exposure on pain intensity levels among older adults who experience chronic pain. Investigators examine the effects of nature on: the experience of chronic pain, on pain catastrophizing, and on attention restoration.

Detailed Description

Nature has been used to reduce pain in the context of acute pain (e.g., during painful medical procedures) but nature has not been examined as an intervention strategy to address chronic pain. Second, the mechanism though which nature might reduce the experience of pain is not well understood. Participants are cognitively intact individuals aged 60-90 who experience chronic pain and who rate their health as fair, good or excellent. Participants are randomly assigned to one of three conditions: virtual reality (VR) nature; VR built environment; or control. Researchers examine effects of VR nature exposure on the experience of chronic pain, pain catastrophizing, and on attention restoration as well as the relations among these variables.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Basic Science
Masking
None

Eligibility Criteria

Ages
60 Years to 90 Years (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • rate health as "fair" "good" or "excellent"
  • experience chronic pain
  • cognitively intact
  • do not use wheelchair

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Experience of chronic pain

Time Frame: up to 3 weeks; from date of randomization until 2nd data collection date

rating of pain intensity, on scale of 1-10

Secondary Outcomes

  • Pain catastrophizing(up to 3 weeks; from date of randomization until 2nd data collection date)
  • cognitive functioning(up to 3 weeks; from date of randomization until 2nd data collection date)

Investigators

Sponsor Class
Other
Responsible Party
Sponsor

Study Sites (2)

Loading locations...

Similar Trials